Tandem Diabetes Care, Inc.
Common Stock · USD · NASDAQ
Price
$16.04
Cap
—
Earnings
—
30d Trend
-14.7%
BRAIN47 SIGNAL
Raw weighted: 39×Macro 0.99 (−1%)=39
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 80%
BRAIN47 HORIZON ANALYSIS
Limited short-term thesis
BRAIN47'S ASSESSMENT
I rate Tandem Diabetes Care, Inc. at 39/100 — a WEAK reading on the Brain47 Signal. The strongest factor is quality at 57/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.
DETAILED ANALYSIS
Limited short-term thesis. Quality (57) and Fundamentals (50) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. I classify this as a speculative position — elevated volatility at 86% and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.